Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapyNatalia Szóstak, Michał Budnik, Katarzyna Tomela, et al.
Oncotarget|June 25, 2019
Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitorTomasz Kolenda, Piotr Rutkowski, Michał Michalak, et al.
Pharmaceutics|July 2, 2021
Light- and Melanin Nanoparticle-Induced Cytotoxicity in Metastatic Cancer CellsVictoria R Gabriele, Robabeh M Mazhabi, Natalie Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in miceTomasz Switaj, Ahmad Jalili, Anna B Jakubowska, et al.
Oncoimmunology|November 1, 2018
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patientsEliza Kwiatkowska-Borowczyk, Patrycja Czerwińska, Jacek Mackiewicz, et al.
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
Acta Biochimica Polonica|June 7, 2013
Development of a new, simple and cost-effective diagnostic tool for genetic screening of hereditary colorectal cancer--the DNA microarray assayZoran Stojcev, Tomasz Banasiewicz, Michał Kaszuba, et al.
EXCLI Journal|January 7, 2025
Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanomaTomasz Kolenda, Kacper Guglas, Maciej Stasiak, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAFV600 mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
Hereditary Cancer in Clinical Practice|March 8, 2017
Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancerTomasz Huzarski, Barbara Górecka-Szyld, Jowita Huzarska, et al.
Pageof 12